IN THE NEWS
Pattern Announces Company Presentation at BIO-Europe 2024
REDMOND, Wash., Oct. 14, 2024-- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced the Company has been invited to present at the BIO- Europe® 2024 conference. The 30th annual edition of BIO-Europe will take place from November 4-6, [...]
Pattern’s ProSpectral™ Passes EMC Certifications Required for Commercial Sales
• Company meets all testing required to meet global EMC standards • Broadens ProSpectral™ multi-disease diagnostics research platform to serve diverse growth markets REDMOND, WA, September 24, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") is proud to [...]
Pattern and the Medical College of Wisconsin Launch New Pilot Study to Assess Detection of Head, Neck and Lung Cancers Through ProSpectral™ Saliva Analysis
Research collaboration leverages Pattern's ProSpectral™ multi-disease hyperspectral diagnostics research platform Potentially ushers in a new era of early detection cancer screening REDMOND, WA, August 21, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Pattern and [...]
Pattern Announces Company Presentation at LSX World Congress USA
REDMOND, WA, August 7, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced the Company will be presenting at the LSX World Congress USA, which will be held in Boston, MA at the Hynes Convention Center. The [...]
Pattern CEO Joins Nobelists and Global Leaders Looking Toward the Next Decade in the International Release of ‘IGNITE.2034’
Mark Anderson, Chair and CEO, joins renowned authors in contributing chapter entitled "The Future of AI: Pattern Discovery, Explainable AI, and Ethical AI"REDMOND, WA, August 6, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced the publication of [...]
Pattern’s Ovarian Cancer Combination Candidate Shows Promising In Vivo Results
Targets high-grade serous ovarian cancer, the most common and deadliest form of gynecologic cancer Underscores potential of Pattern Discovery Engine™ to uncover novel therapeutic combinations for hard-to-treat cancers REDMOND, WA, July 30, 2024 -- Pattern Computer®, Inc. ("Pattern" or [...]
Pattern Computer ProSpectral Device Found to be “Potentially Disruptive” in Clinical Diagnostics and Military Bio Attack Roles
New paper on sensing research collaboration with national labs available on medRxiv Hyperspectral sensing shown to enable agnostic reagent-free diagnostics Study addresses clear and critical need for pathogen agnostic diagnostics that can be quickly and effectively performed at point [...]
Pattern Announces Filing of Provisional Patent Applications for Treatment of Metastatic Castration-Resistant Prostate Cancer
Continued expansion of Pattern's IP portfolio Significant progress in expanding industry-leading oncology pipeline REDMOND, WA, June 12, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") announced at the Bio International Conference in San Diego that it is filing [...]
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
REDMOND, WA, May 22, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer (HGSOC) program. Armed with a [...]
Pattern to Present at 2024 BIO International Convention
REDMOND, WA, May 21, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Mark R. Anderson, Chairman and CEO, will present at the upcoming 2024 BIO International Convention, June 3 - 6, 2024, in San Diego, [...]